Cardinal Health, Inc. (CAH) FY2024 Annual P&L / Income Statement
2023-07-01 to 2024-06-30
Revenue by Business Segment
2023-07-01 to 2024-06-30
Swipe to see the full flow
Chart details
Cardinal Health, Inc. (CAH) FY2024 Annual P&L / Income Statement
Income statement for 2023-07-01 through 2024-06-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.
- Revenue
- 226,827,000,000 US dollars
- Cost of products sold
- 219,413,000,000 US dollars
- Gross margin
- 7,414,000,000 US dollars
- Operating costs, including other operating expenses (calculated)
- 6,171,000,000 US dollars
- Operating earnings/(loss)
- 1,243,000,000 US dollars
- Other income (expense), net (calculated)
- negative 42,000,000 US dollars
- Earnings/(loss) before income taxes
- 1,201,000,000 US dollars
- Provision for income taxes
- 348,000,000 US dollars
- Net earnings/(loss)
- 853,000,000 US dollars
- GMPD
- 12,381,000,000 US dollars
- Other Operating Segment
- 4,512,000,000 US dollars
- Pharmaceutical and Specialty Solutions
- 210,019,000,000 US dollars
- Distribution, selling, general and administrative expenses
- 5,000,000,000 US dollars
- Restructuring and employee severance
- 175,000,000 US dollars
- Amortization and other acquisition-related costs
- 284,000,000 US dollars
- Impairments and (gain)/loss on disposal of assets, net
- 634,000,000 US dollars
- Litigation (recoveries)/charges, net
- 78,000,000 US dollars
- Revenue before reconciliation (calculated)
- 226,912,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
- Total operating earnings/(loss)
- negative 85,000,000 US dollars. Reported reconciliation to consolidated revenue.
- GMPD costs (calculated)
- 12,289,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- Other Operating Segment costs (calculated)
- 4,089,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- Pharmaceutical and Specialty Solutions costs (calculated)
- 208,004,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- Reconciling items (calculated)
- 1,202,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
Chart connections
- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
- Of which attributable to Cardinal Health, Inc.: $852.00 M; to noncontrolling interests: $1.00 M.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Gross margin
3.3%
Gross profit / revenue
Operating margin
0.5%
Operating profit / revenue
Cash conversion
441.0%
Operating cash / net income, same period
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
